Showing all 11 results

  • Breztri Aerosphere budesonide glycopyrrolate formoterol fumarate
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) Online For Sale

    $299.25

    DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

    MANUFACTURER: AstraZeneca Pharmaceuticals LP

    USAGE: Oral

    MEDICINE APPROVED BY:

    Food and Drug Administration (FDA)

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Breztri Aerosphere is a prescription medication that combines three active ingredients: budesonide, glycopyrrolate, and formoterol fumarate. This combination inhaler is primarily used in the management of chronic obstructive pulmonary disease (COPD), a chronic lung condition characterized by airflow limitation and breathing difficulties.

    Select options This product has multiple variants. The options may be chosen on the product page
  • In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Clenbuterol Harasawa Online For Sale

    $100.80

    DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)

    MANUFACTURER: Harasawa

    USAGE: Oral

    MEDICINE APPROVED BY:

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Clenbuterol Harasawa is a prescription medication that belongs to the drug class of beta-2 adrenergic receptor agonists. It is used in Japan to treat asthma and chronic obstructive pulmonary disease (COPD). 

    Select options This product has multiple variants. The options may be chosen on the product page
  • Kalydeco ivacaftor
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Kalydeco (ivacaftor) Online For Sale

    From $7,096.95

    DISEASE INDICATIONS: Cystic Fibrosis

    MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Kalydeco, with its active ingredient ivacaftor, is a prescription medication primarily used in the treatment of a specific form of cystic fibrosis (CF) caused by certain gene mutations.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Lucaftor lumacaftor ivacaftor
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Lucaftor (lumacaftor/ivacaftor) Online For Sale

    $2,993.55

    DISEASE INDICATIONS: Cystic Fibrosis

    MANUFACTURER: Gador SA

    USAGE: Oral

    MEDICINE APPROVED BY:

    ANMAT (ARG)

    Lucaftor (lumacaftor/ivacaftor) is a prescription medication that belongs to the drug class of potentiator and corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. It is used to treat cystic fibrosis (CF) in patients 2 years of age and older who have at least one F508del mutation in the CFTR gene.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Orkambi lumacaftor ivacaftor
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Orkambi (lumacaftor/ivacaftor) Online For Sale

    From $10,590.30

    DISEASE INDICATIONS: Cystic Fibrosis

    MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Therapeutic Goods Administration (TGA)

    Orkambi is a prescription medication that combines two active ingredients: lumacaftor and ivacaftor. It is primarily used in the treatment of cystic fibrosis (CF), a genetic disorder that affects the lungs and other organs, leading to the production of thick and sticky mucus.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Symdeko tezacaftor ivacaftor
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Symdeko (tezacaftor / ivacaftor) Online For Sale

    $38,631.60

    DISEASE INDICATIONS: Cystic Fibrosis

    MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Symdeko is a prescription medication that combines two active ingredients: tezacaftor and ivacaftor. It is primarily used in the treatment of cystic fibrosis (CF), a genetic disorder that affects the lungs and other organs, leading to the production of thick and sticky mucus.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Symkevi tezacaftor ivacaftor
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Symkevi (tezacaftor/ivacaftor) Online For Sale

    $5,615.40

    DISEASE INDICATIONS: Cystic Fibrosis

    MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Symkevi (tezacaftor/ivacaftor) is a combination medication used to treat cystic fibrosis in patients aged 12 years and older who have certain genetic mutations.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Tezspire tezepelumab ekko
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Tezspire (tezepelumab-ekko) Online For Sale

    $6,562.50

    DISEASE INDICATIONS: Asthma

    MANUFACTURER: Amgen / AstraZeneca AB

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    Food and Drug Administration (FDA)

    Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and adolescents 12 years of age and older. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.

    Select options This product has multiple variants. The options may be chosen on the product page
  • In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online For Sale

    $740.25

    DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma

    MANUFACTURER: GlaxoSmithKline

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Trelegy Ellipta is a medication that combines three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. It is available in the form of an inhalation powder and is primarily used in the management of chronic obstructive pulmonary disease (COPD).

    Select options This product has multiple variants. The options may be chosen on the product page
  • Trikafta
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Online For Sale

    From $38,325.00

    DISEASE INDICATIONS: Cystic Fibrosis

    MANUFACTURER: Vertex Pharmaceuticals Incorporated

    USAGE: Oral

    MEDICINE APPROVED BY:

    Food and Drug Administration (FDA)

    Trikafta is a medication that combines three active ingredients: elexacaftor, tezacaftor, and ivacaftor. It is primarily used in the treatment of cystic fibrosis (CF), a genetic disorder that affects the lungs and other organs.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Yupelri revefenacin
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Yupelri (revefenacin) Online For Sale

    DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

    MANUFACTURER: Theravance Biopharma

    USAGE: Oral

    MEDICINE APPROVED BY:

    Food and Drug Administration (FDA)

    Yupelri is a medication with the generic name revefenacin, and it is a long-acting muscarinic antagonist (LAMA) used in the treatment of chronic obstructive pulmonary disease (COPD).

    Read more